| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |